Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

320 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Trastuzumab-MMAU Antibody-Auristatin Conjugates: Valine-Glucoserine Linker with Stabilized Maleimide Conjugation Improves In Vivo Efficacy and Tolerability.
Goldberg SD, Satomaa T, Aina O, Aitio O, Burke K, Dudkin V, Geist B, Irrechukwu O, Hänninen AL, Heiskanen A, Helin J, Hiltunen JO, Kinyamu-Akunda J, Klein DM, Kohli N, Kotiranta T, Lähteenmäki T, Niemelä R, Pitkänen V, Pynnönen H, Rittase W, Wiley K, Zhou J, Saarinen J. Goldberg SD, et al. Among authors: kohli n. Mol Cancer Ther. 2024 Nov 4;23(11):1530-1543. doi: 10.1158/1535-7163.MCT-23-0591. Mol Cancer Ther. 2024. PMID: 38324296
Antibody Co-Administration Can Improve Systemic and Local Distribution of Antibody-Drug Conjugates to Increase In Vivo Efficacy.
Ponte JF, Lanieri L, Khera E, Laleau R, Ab O, Espelin C, Kohli N, Matin B, Setiady Y, Miller ML, Keating TA, Chari R, Pinkas J, Gregory R, Thurber GM. Ponte JF, et al. Among authors: kohli n. Mol Cancer Ther. 2021 Jan;20(1):203-212. doi: 10.1158/1535-7163.MCT-20-0451. Epub 2020 Nov 11. Mol Cancer Ther. 2021. PMID: 33177153 Free PMC article.
Antitumor activity of a novel bispecific antibody that targets the ErbB2/ErbB3 oncogenic unit and inhibits heregulin-induced activation of ErbB3.
McDonagh CF, Huhalov A, Harms BD, Adams S, Paragas V, Oyama S, Zhang B, Luus L, Overland R, Nguyen S, Gu J, Kohli N, Wallace M, Feldhaus MJ, Kudla AJ, Schoeberl B, Nielsen UB. McDonagh CF, et al. Among authors: kohli n. Mol Cancer Ther. 2012 Mar;11(3):582-93. doi: 10.1158/1535-7163.MCT-11-0820. Epub 2012 Jan 16. Mol Cancer Ther. 2012. PMID: 22248472
MM-141, an IGF-IR- and ErbB3-directed bispecific antibody, overcomes network adaptations that limit activity of IGF-IR inhibitors.
Fitzgerald JB, Johnson BW, Baum J, Adams S, Iadevaia S, Tang J, Rimkunas V, Xu L, Kohli N, Rennard R, Razlog M, Jiao Y, Harms BD, Olivier KJ Jr, Schoeberl B, Nielsen UB, Lugovskoy AA. Fitzgerald JB, et al. Among authors: kohli n. Mol Cancer Ther. 2014 Feb;13(2):410-25. doi: 10.1158/1535-7163.MCT-13-0255. Epub 2013 Nov 26. Mol Cancer Ther. 2014. PMID: 24282274
Knowledge of Mandatory Reporting Laws and Recording of Clients' Abuse Data: Effects of a Sexual Health Curriculum Training for Health Students in Tanzania.
Mushy SE, Lukumay GG, Massae AF, Mkoka DA, Rohloff CT, Kohli N, Mgopa LR, Mwakawanga DL, Mkonyi E, Ross MW, Trent M, Rosser BRS. Mushy SE, et al. Among authors: kohli n. J Child Sex Abus. 2025 Jan 16:1-20. doi: 10.1080/10538712.2025.2450404. Online ahead of print. J Child Sex Abus. 2025. PMID: 39817664
Oxidized phospholipid and transcriptomic signatures of THC-related vaping associated lung injury.
Suber TL, Tabary M, Bain W, Olonisakin T, Lockwood K, Xiong Z, Zhang Y, Kohli N, Furguiele L, Peñaloza H, McVerry BJ, Rose JJ, Shah F, Methé B, Li K, Mallampalli RK, Chen K, Fan L, Morris A, Tyurin VA, Samovich SN, Bayir H, Tyurina YY, Kagan V, Lee JS. Suber TL, et al. Among authors: kohli n. Sci Rep. 2024 Dec 30;14(1):31622. doi: 10.1038/s41598-024-79585-8. Sci Rep. 2024. PMID: 39738089 Free PMC article.
320 results